TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVAPharmaceutical Preparations · SIC 2834 · CIK 0000818686
Revenue FY2025
$17.26B
Net Income
$1.41B
EPS (Basic)
$1.23
Net Margin
8.2%
ROE
17.8%
Total Equity
$7.91B
Shares Out
1.17B
TEVA PHARMACEUTICAL INDUSTRIES LTD — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 10 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Sound Shore Management
Harry Burn
$0.13B
3.8%
(2.1%)
Glenview Capital Management
Glenview Capital Management
$0.17B
2.7%
(23.7%)
Greenlight Capital (DME)
David Einhorn
$0.10B
2.0%
(0.8%)
WCM Investment Management
WCM Investment Management
$1.38B
1.4%
+1.2%
Duquesne Family Office
Stanley Druckenmiller
$0.02B
0.5%
(73.7%)
Adage Capital Management
Adage Capital Management
$0.08B
0.1%
NEW
Capital World Investors
Capital World Investors
$0.42B
0.1%
+41.9%
Bridgewater Associates
Bridgewater Associates
$0.04B
0.0%
+17.6%
ARK Investment Management
ARK Investment Management
$0.00B
0.0%
+0.5%
Holocene Advisors
Holocene Advisors
$0.01B
0.0%
(7.7%)
Insider Transactions
Reading stored insider transactions…